Notably, inhibition of Siglec-10 restrained the secretion of anti-inflammatory cytokines from macrophages and suppressed the expression of inhibitory receptors on CD8+ T cells, resulting in restored cytotoxic activities against tumor cells. This evidence concerns the gene CD8A and neoplasm.